Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

ConditionsHeart; Dysfunction Postoperative, Cardiac Surgery Genetic Predisposition to Disease Atrial Fibrillation Myocardial Infarction Heart Failure

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age20-90

SponsorBrigham and Women's Hospital

About this trial

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

Eligibility criteria

Qualifiers

Undergoing heart surgery

Willing to provide consent

Disqualifiers

Enrolled in a concurrent drug or device trial that precludes concurrent enrollment

Trial design

Treatments tested in this trial

Not listed

Trial groups

4,000 Participants

are grouped into 1 trial group

Locations

Brigham and Women's Hospital02115, BostonMassachusetts, United States

UT Southwestern Medical Center75390-9068, DallasTexas, United States

Department Texas Heart Institute at St. Luke's Episcopal Hospital77225, HoustonTexas, United States

Sponsors and collaborators

Brigham and Women's Hospital

Lead sponsor

Johns Hopkins University

Sponsor institution

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Texas Heart Institute

Collaborator

University of Texas Southwestern Medical Center

Collaborator

Johns Hopkins University

Collaborator

Source ClinicalTrials.gov